THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Michael Cookson to Antineoplastic Agents, Hormonal

Back to Details
This is a "connection" page, showing publications Michael Cookson has written about Antineoplastic Agents, Hormonal.
Michael Cookson
Connection Strength
0.865
Antineoplastic Agents, Hormonal
  1. Mechanisms leading to the development of hormone-resistant prostate cancer. Urol Clin North Am. 2006 May; 33(2):201-10, vii.
    View in: PubMed
    Score: 0.259
  2. Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med. 2020 06 04; 382(23):2187-2196.
    View in: PubMed
    Score: 0.172
  3. The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer. Investig Clin Urol. 2020 02; 61(Suppl 1):S3-S7.
    View in: PubMed
    Score: 0.168
  4. The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3. Oncology (Williston Park). 2016 Feb; 30(2):187-95, 199.
    View in: PubMed
    Score: 0.127
  5. Castration-resistant prostate cancer: AUA Guideline. J Urol. 2013 Aug; 190(2):429-38.
    View in: PubMed
    Score: 0.105
  6. The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results. Urology. 1997 Mar; 49(3A Suppl):46-55.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES